Clinical Trial Update: Effect of Ranibizumab on Malignant Conjunctival Neoplasia [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the effect of Ranibizumab on malignant conjunctival neoplasms has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Conjunctival Neoplasms

Drugs mentioned

• Ranibizumab (ranibizumab)

Snippet

Sponsor: The New York Eye Cancer Center | Conditions: Conjunctival Neoplasms | Phase 1 | Status: COMPLETED | Results posted: 2013-06-06